Home > PE Ratio > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
PE (Price/Earnings) Ratio

The Current P/E Ratio of GLENMARK LIFE SCIENCES is 30.34.

Share Price ₹1,048.9Nov 22,2024
Market Cap ₹12,849.0 Cr
Earnings-TTM₹423.5 CrTTM-Standalone Results
Price/Earnings30.34xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of GLENMARK LIFE SCIENCES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GLENMARK LIFE SCIENCES is calculated as :

Current Market Cap [ ₹12,849.0 Cr] as on Nov 22,2024

(/) Earnings [ ₹423.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 30.34x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GLENMARK LIFE SCIENCES , the investors are currently willing to pay 30.34 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GLENMARK LIFE SCIENCES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GLENMARK LIFE SCIENCES over the last five years.

Historical PE (Price/Earnings) ratio chart of GLENMARK LIFE SCIENCES


PE Ratio Performance Analysis for GLENMARK LIFE SCIENCES

- GLENMARK LIFE SCIENCES 's latest p/e ratio is 30.34x.

- GLENMARK LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.78x.

- GLENMARK LIFE SCIENCES 's operated at median p/e ratio of 10.28x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLENMARK LIFE SCIENCES 's p/e ratio peaked in Mar2024 at 20.17x.

- GLENMARK LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does GLENMARK LIFE SCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GLENMARK LIFE SCIENCES 423.5030.3412,849.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.73431,352.0
CIPLA LTD4,485.2226.76120,035.0
DR REDDYS LABORATORIES LTD5,406.8018.73101,286.0
ZYDUS LIFESCIENCES LTD4,298.9022.2195,461.4
DIVIS LABORATORIES LTD1,836.0086.75159,265.0
MANKIND PHARMA LTD2,124.8648.11102,231.0
TORRENT PHARMACEUTICALS LTD1,802.0059.55107,306.0
LUPIN LTD2,651.9435.6194,430.6
AUROBINDO PHARMA LTD3,598.8319.7571,069.8
ABBOTT INDIA LTD1,284.6645.8258,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GLENMARK LIFE SCIENCES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.73x
Max industry PE 86.75x
Median industry PE 35.61x
Average industry PE 39.30x



You may also like the below Video Courses